A Testa

Author PubWeight™ 78.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994 2.14
2 Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 1993 1.56
3 Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial. Cancer 1994 1.55
4 Kenny-Caffey syndrome in two sibs born to consanguineous parents: evidence for an autosomal recessive variant. Am J Med Genet 1992 1.26
5 Prosthetic repair of a perforated Amyand's hernia: hazardous or feasible? Hernia 2007 1.26
6 Mapping of avirulence genes in Phytophthora infestans with amplified fragment length polymorphism markers selected by bulked segregant analysis. Genetics 2001 1.16
7 The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant 2012 1.15
8 Efficacy of double intrauterine insemination in controlled ovarian hyperstimulation cycles. Fertil Steril 1999 1.04
9 Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci 2014 1.02
10 Realising the European Network of Biodosimetry (RENEB). Radiat Prot Dosimetry 2012 0.99
11 Neuropsychological features of benign partial epilepsy in children. Ital J Neurol Sci 1990 0.98
12 Permanent Genetic Resources added to Molecular Ecology Resources Database 1 April 2010 - 31 May 2010. Mol Ecol Resour 2010 0.97
13 Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen) J Am Soc Nephrol 2000 0.96
14 Thyroid carcinoma mimicking a toxic adenoma. Eur J Nucl Med 1990 0.96
15 Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses. Ultrasound Obstet Gynecol 2009 0.95
16 Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade. Pharmacogenomics J 2004 0.95
17 Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer. Br J Cancer 2003 0.93
18 Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects. Nephrol Dial Transplant 2001 0.92
19 Acute pain syndrome at tumour site in neoplastic patients treated with vinorelbine: report of unusual toxicity. Eur J Cancer 1994 0.91
20 ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1. Kidney Int 2000 0.91
21 Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy. Anticancer Drugs 1993 0.91
22 Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum Genet 1997 0.90
23 Single agent paclitaxel in advanced squamous cell head and neck carcinoma. Eur J Cancer 1996 0.90
24 Anti-neutrophil cytoplasm antibodies in patients with monoclonal gammopathies. J Clin Lab Immunol 1990 0.90
25 Management of thyrotoxic crisis. Eur Rev Med Pharmacol Sci 2005 0.90
26 Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Cancer 1996 0.89
27 Severe EBV hepatitis treated with valganciclovir. Infection 2012 0.87
28 Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron 1990 0.86
29 Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2. Cancer Immunol Immunother 1998 0.86
30 Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. Nutr Metab Cardiovasc Dis 2011 0.86
31 Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy. Eur J Clin Microbiol Infect Dis 2008 0.85
32 Chromosomal deletion in isolates of Phytophthora infestans correlates with virulence on R3, R10, and R11 potato lines. Mol Plant Microbe Interact 2001 0.85
33 Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre. Clin Endocrinol (Oxf) 1997 0.85
34 Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study. Clin Ter 1999 0.85
35 Person X situation interactionism in self-encoding (I am...when...): implications for affect regulation and social information processing. J Pers Soc Psychol 2001 0.84
36 Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 1989 0.84
37 Traction on the retina induced by saccadic eye movements in the presence of posterior vitreous detachment. Biomech Model Mechanobiol 2010 0.83
38 Essential amino acid supplementation in patients with severe COPD: a step towards home rehabilitation. Monaldi Arch Chest Dis 2012 0.83
39 [Adult congenital anomalies of the coronary arteries described over 31 years of angiographic studies in the Asturias Principality: main angiographic and clinical characteristics]. Rev Esp Cardiol 2001 0.83
40 A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma. J Chemother 1993 0.83
41 The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis. Am J Hypertens 2000 0.83
42 Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases. Br J Cancer 1993 0.83
43 Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer: a phase II study of the Southern Italy Oncology Group (GOIM). Anticancer Drugs 1997 0.83
44 Imaging in gynecological disease (5): clinical and ultrasound characteristics in fibroma and fibrothecoma of the ovary. Ultrasound Obstet Gynecol 2009 0.82
45 Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial. Cancer 1995 0.82
46 Thyroid cancer in suppressed contralateral lobe of patients with hot thyroid nodule. Eur J Cancer 1993 0.82
47 Cytogenetic effects in lymphocytes from children exposed to radiation fall-out after the Chernobyl accident. Mutat Res 1997 0.82
48 [Anthropometric measurements of the male inguinal canal]. Minerva Chir 1998 0.82
49 DG-RAR for the treatment of symptomatic grade III and grade IV haemorrhoids: a 12-month multi-centre, prospective observational study. Eur Surg 2013 0.81
50 Mitomycin "C" and vinorelbine as second line chemotherapy for metastatic breast carcinoma. Tumori 1994 0.81
51 Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study. Eur J Phys Rehabil Med 2013 0.81
52 Inguinal hernia and atrial septal defect in Tel Hashomer camptodactyly syndrome: report of a new case expanding the phenotypic spectrum of the disease. Am J Med Genet 1993 0.81
53 A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy. Anticancer Res 1994 0.80
54 Imaging in gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary. Ultrasound Obstet Gynecol 2012 0.80
55 Importance of the type of soil for the induction of micronuclei and the growth of primary roots of Vicia faba treated with the herbicides atrazine, glyphosate and maleic hydrazide. Mutat Res 1992 0.80
56 Brain natriuretic peptide and acute coronary syndrome. Minerva Med 2005 0.80
57 935 MHz cellular phone radiation. An in vitro study of genotoxicity in human lymphocytes. Int J Radiat Biol 2006 0.79
58 A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Eur J Cancer 1993 0.79
59 Effect of protein A immunoadsorption on panel lymphocyte reactivity in hyperimmunized patients awaiting a kidney graft. Transplantation 1990 0.79
60 Lower lip pits and complete idiopathic precocious puberty in a patient with Kabuki make-up (Niikawa-Kuroki) syndrome. Am J Med Genet 1993 0.79
61 Absence of genotoxicity in human blood cells exposed to 50 Hz magnetic fields as assessed by comet assay, chromosome aberration, micronucleus, and sister chromatid exchange analyses. Bioelectromagnetics 2004 0.79
62 Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. Br J Cancer 1996 0.79
63 Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile? Oncology 2004 0.79
64 Lung and ultrasound: time to "reflect". Eur Rev Med Pharmacol Sci 2011 0.78
65 Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer. Eur J Cancer 1994 0.78
66 Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide. Exp Clin Endocrinol 1993 0.78
67 Review of dilated cardiomyopathies. Dilated cardiomyopathies and altered prothrombotic state: a point of view of the literature. Panminerva Med 2005 0.78
68 Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature. Ultrasound Obstet Gynecol 2012 0.78
69 Total or partial percutaneous renal ablation in the treatment of renovascular hypertension: radiological and clinical aspects. Br J Radiol 1989 0.78
70 Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinoma. Anticancer Res 1993 0.78
71 Alpha1-antitrypsin phenotypes and anti-neutrophil cytoplasmic auto-antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999 0.78
72 Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma. Anticancer Res 1994 0.78
73 MR characterization of hepatic lesions by t-null inversion recovery sequence. J Comput Assist Tomogr 1990 0.78
74 5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Anticancer Res 1999 0.77
75 Preoperative prediction of lymph node metastasis and deep stromal invasion in women with invasive cervical cancer: prospective multicenter study using 2D and 3D ultrasound. Ultrasound Obstet Gynecol 2015 0.77
76 Prevalence of obesity in young adults with acute lymphoblastic leukemia. Int J Clin Lab Res 1994 0.77
77 Recurrence of immunoglobulin A nephropathy with immunoglobulin A antineutrophil cytoplasmic antibodies following renal transplantation. Am J Kidney Dis 1997 0.77
78 Intracavitary beta-interferon for the management of pleural and/or abdominal effusions in patients with advanced cancer refractory to chemotherapy. In Vivo 1992 0.77
79 A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre. Horm Metab Res 1995 0.77
80 [Abdominal complications in peritoneal dialysis]. Nephrologie 2002 0.77
81 Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen. Ann Oncol 2001 0.77
82 Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease. Q J Nucl Med 1996 0.77
83 [Effect of smoking-machine parameters on the genetoxic activity of cigarette gas phase, estimated on human lymphocyte and yeast (author's transl)]. Mutat Res 1980 0.77
84 Torasemide, a new loop diuretic, in patients with chronic renal failure. Nephron 1990 0.77
85 Induction of micronuclei in Vicia faba root tips treated in different soils with the herbicide alachlor. Mutat Res 1990 0.77
86 Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with glutathione protection in patients with advanced head and neck cancer. Med Oncol Tumor Pharmacother 1992 0.76
87 A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma. Clin Ter 1999 0.76
88 Relationship between gastro-oesophageal reflux and gastric activity in newborns assessed by combined intraluminal impedance, pH metry and epigastric impedance. Neurogastroenterol Motil 2006 0.76
89 Levodopa therapy reduces DNA damage in peripheral blood cells of patients with Parkinson's disease. Cell Biol Toxicol 2008 0.76
90 Dopamine counteracts the acute renal effects of cyclosporine in normal subjects. Transplant Proc 1988 0.76
91 Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM). Am J Clin Oncol 1999 0.76
92 Effects of plasma-protein A immunoadsorption on idiopathic nephrotic syndrome recurring after renal transplantation. Ann Med Interne (Paris) 1992 0.76
93 Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies. J Am Soc Nephrol 1999 0.75
94 Disappearance of proteinuria after immunoadsorption in a patient with focal glomerulosclerosis. Lancet 1990 0.75
95 Severe Shwachman-Diamond syndrome and invasive parvovirus B19 infection. Pediatr Hematol Oncol 1997 0.75
96 A clinical study of Addison's disease. Exp Clin Endocrinol 1987 0.75
97 Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM). Br J Cancer 1995 0.75
98 [The importance of house dust as a cause of allergic manifestations in Naples]. Folia Allergol (Roma) 1967 0.75
99 Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck. ORL J Otorhinolaryngol Relat Spec 1994 0.75
100 Captopril and aspirin in treatment of renal microangiopathy in primary antiphospholipid syndrome. Am J Kidney Dis 1995 0.75
101 Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck. Am J Clin Oncol 1995 0.75
102 [Scintigraphy in the diagnosis and follow-up of bone neoplasms in childhood]. Minerva Pediatr 1987 0.75
103 Cerebral organization for language in Down's syndrome patients. Cortex 1991 0.75
104 [Allergic respiratory syndromes due to coffee powder]. Folia Allergol (Roma) 1966 0.75
105 Primary papillary carcinoma arising from median ectopic thyroid in multinodular goitre. Eur J Cancer 1991 0.75
106 Amiodarone-induced thyroid dysfunction in clinical practice. Eur Rev Med Pharmacol Sci 2006 0.75
107 Autonomously functioning thyroid adenoma in a seven year old boy. Thyroidology 1991 0.75
108 Subcutaneous recombinant-human-erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer. Int J Oncol 1992 0.75
109 [Respiratory syndromes and food allergy]. Folia Allergol (Roma) 1967 0.75
110 [Amiodarone-induced thyroid pathology]. Clin Ter 1987 0.75
111 [The allergic factor in the genesis of hemicrania]. Folia Allergol (Roma) 1966 0.75
112 Anti-neutrophil cytoplasm antibodies in patients with ACR criteria for polyarteritis nodosa: help for systemic vasculitis classification? Autoimmunity 1995 0.75
113 Calibration curves for biological dosimetry by fluorescence in situ hybridisation. Radiat Prot Dosimetry 2001 0.75
114 Captopril but not acebutolol, prazosin or indomethacin decreases postexercise proteinuria. Nephron 1991 0.75
115 [Xeroductogalactography. Case reports]. Radiol Med 1987 0.75
116 Plasmapheresis in the therapy of hyperthyroidism associated with leukopenia. Haematologica 1991 0.75
117 Cognitive performances in parkinsonians before and after bromocriptine therapy. Acta Neurol (Napoli) 1986 0.75
118 [Bornaprine in the treatment of parkinsonian tremor]. Riv Neurol 1985 0.75
119 Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion. Anticancer Res 1999 0.75
120 Treatment of massive hemorrhage after renal biopsy with percutaneous arterial obliteration. Nephron 1988 0.75
121 A phase II study of levofolinic acid and 5-fluorouracil plus cisplatin in patients with advanced head and neck squamous cell carcinoma. Oncology 1993 0.75
122 [Retrospective study of 177 patients admitted to the coronary unit in whom the diagnosis of myocardial infarct was excluded: subgroup at high risk for cardiovascular accidents]. G Ital Cardiol 1987 0.75
123 [Amiodarone and thyroid function]. Clin Ter 1987 0.75
124 [Thrombotic microangiopathies in HIV infection: 4 cases]. Rev Med Interne 1996 0.75
125 [Intracystic papillary carcinoma of the breast assessed preoperatively with magnetic resonance]. Radiol Med 1988 0.75
126 Rigid mask-like face, ear anomalies, deafness, preaxial polydactyly and toe malformations in a patient with normal intelligence: a new entity? Clin Dysmorphol 1994 0.75
127 [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study]. Minerva Pediatr 1988 0.75
128 Diagnostic and therapeutic approach to acute pulmonary embolism in an emergency department. Eur Rev Med Pharmacol Sci 2006 0.75
129 Hemodiafiltration in pentobarbital poisoning. Ren Fail 1996 0.75
130 [Von Recklinghausen neurofibromatosis and renovascular hypertension]. Minerva Urol Nefrol 1987 0.75
131 Escape phenomenon after successful bromocriptine and octreotide treatment in thyroid stimulating hormone secreting pituitary adenoma residual tissue. Eur J Cancer 1994 0.75
132 [Iodide-induced thyrotoxicosis. Clinical case]. G Clin Med 1988 0.75
133 Modulation of pokeweed mitogen-induced B cell differentiation by polymorphonuclear cells: effects of bacterial lipopolysaccharides. Microbios 1994 0.75
134 Triplication of alpha-globin genes is responsible for unusual alpha 113Leu/alpha 113His-globin chain ratios in sheep. Biochem Genet 1987 0.75
135 [Prolonged cortisone therapy in treatment of allergic diseases]. Riforma Med 1965 0.75
136 [Magnetic resonance of the prostate: critical evaluation of diagnostic possibilities]. Radiol Med 1989 0.75
137 Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule. J Cancer Res Clin Oncol 1994 0.75
138 [Preeclampsia and peripartum cardiomyopathy: infrequent association]. Nefrologia 2001 0.75
139 [Laboratory diagnosis: correlated health and environmental risks]. Clin Ter 2001 0.75
140 Nasal bone osteochondroma in a horse. Vet Rec 2009 0.75
141 Cisplatin plus vp16 as salvage treatment for advanced breast-carcinoma resistant or recurrent after 1st line chemotherapy for metastatic disease. Oncol Rep 1995 0.75
142 [Indications and limits of the cutaneous tests in the diagnosis of allergic diseases: personal observations during the 10-year-period 1956-1966]. Folia Allergol (Roma) 1969 0.75
143 [The dynamic self-regulating prosthesis. A new method for the treatment of hernias in the inguinal area: preliminary notes on 153 cases]. Minerva Chir 1997 0.75
144 [Endocrinology. Hypothyroidism caused by iodine excess]. G Clin Med 1989 0.75
145 Molecular imaging and magnetic resonance imaging in early diagnosis of Alzheimer's disease. A literature review. Neuroradiol J 2009 0.75
146 [Amiodarone]. Ann Ital Med Int 1990 0.75
147 [Clinical dosimetry in xeromammography using the low dose system]. Radiol Med 1987 0.75
148 Effects of naloxone on adrenocorticotrophin (ACTH) and cortisol in obese subjects. Horm Metab Res 1992 0.75
149 [Effect of prolonged corticosteroid treatment on the immediate type of specific cutaneous reaction]. Folia Allergol (Roma) 1966 0.75
150 CT assessment in canine meningoencephalomyelitis. Vet Res Commun 2008 0.75
151 Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach. J Chemother 1994 0.75
152 [Observations concerning the effects of the gaseous phase of cigarette smoke on the motility of Dunaliella bioculata Butcher (strain A 1)]. C R Acad Sci Hebd Seances Acad Sci D 1967 0.75
153 Comparison of the side effects of therapeutic cytapheresis and those of other types of hemapheresis. Haematologica 1991 0.75
154 Hydroxyurea modulates 5-fluorouracil antineoplastic activity in advanced head and neck carcinoma pretreated with chemotherapy. Anticancer Drugs 1992 0.75
155 Heart failure and therapy. Minerva Cardioangiol 2005 0.75
156 Pharmacological modulation of 5-fluorouracil and its clinical implications: an overview. In Vivo 1994 0.75
157 Polymorphisms in the genes of the renin system and progression of renal disease: a critical review. Adv Nephrol Necker Hosp 2001 0.75
158 Myocardial revascularization through a mini-thoracotomy with thoracoscopic assistance. Eur J Cardiothorac Surg 1998 0.75
159 Treatment of severe renovascular hypertension by percutaneous transluminal renal angioplasty in patients with solitary functioning kidney. Effects on blood pressure and renal function. Nephron 1988 0.75
160 Second line chemotherapy for metastatic colorectal carcinoma. Oncol Rep 1996 0.75
161 [Physiological effects of iodine on the thyroid function: thyroid autoregulation]. G Clin Med 1989 0.75
162 Plasma exchange in Graves' ophthalmopathy. Prog Clin Biol Res 1990 0.75
163 Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas. Am J Clin Oncol 1994 0.75
164 HLA haplotypes and susceptibility to Graves' disease. Horm Res 1992 0.75
165 [Chronic renal failure]. Soins Chir 1994 0.75
166 Subcutaneous low-dose interleukin-2 and intravenous 5-fluorouracil plus high-dose levofolinic acid as salvage treatment for metastatic colorectal carcinoma. Anticancer Drugs 1996 0.75
167 Induction of micronuclei in Vicia faba root tips treated with heavy metals (cadmium and chromium) in the presence of NTA. Mutat Res 1988 0.75
168 Mitomycin C and lonidamine as second-line treatment of advanced colorectal cancer patients. Anticancer Res 1996 0.75
169 Single agent vinorelbine in the treatment of unresectable lung metastases from colorectal cancer. Oncol Rep 1996 0.75
170 Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study. Anticancer Res 2000 0.75
171 [Clinico-experimental research on a case of blepharochalasis]. G Ital Dermatol Minerva Dermatol 1969 0.75
172 Major muscle calcifications of the neck after non-traumatic rhabdomyolysis with acute renal failure. Nephrol Dial Transplant 1990 0.75
173 Alternation of hypo- and hypercalcemia in a parathyroidectomized patient with breast cancer. Horm Res 1995 0.75
174 [Magnetic resonance of the breast. Clinical experience with a dedicated coil]. Radiol Med 1988 0.75
175 Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma. Henry Ford Hosp Med J 1989 0.75
176 How to use the C-reactive protein in cardiac disease? Minerva Cardioangiol 2005 0.75
177 Kinetics of the Hb A to Hb C switch and erythropoietin plasma levels in sheep. Anim Genet 1988 0.75
178 Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study. Anticancer Drugs 1996 0.75
179 [Demonstration of the value of iron as an organ-specific contrast medium in magnetic resonance of the liver. A case]. Radiol Med 1988 0.75
180 [Allergic dermatosis caused by direct black (soluble azoic dye)]. Folia Allergol (Roma) 1968 0.75
181 Elf regimen in advanced gastrointestinal malignancies - an analysis of its clinical effectiveness and toxicity. Int J Oncol 1994 0.75
182 Effects of uremia, acetate and bicarbonate dialysis on beta-adrenergic responsiveness as assessed by epinephrine-stimulated adenylate cyclase. Am J Nephrol 1989 0.75
183 Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis. Nephron 1993 0.75
184 [Specific desensitizing therapy in the treatment of respiratory allergic diseases]. Folia Allergol (Roma) 1968 0.75
185 [Pollinosis in Naples: characteristics and incidence in our case statistics from 1958 to 1964]. Folia Allergol (Roma) 1967 0.75
186 [Follow-up pulmonary scintigraphy of diaphragmatic hernias surgically treated at birth]. Minerva Pediatr 1987 0.75
187 A phase I-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma. Acta Oncol 1994 0.75